Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDAH1 | O94760 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
| ▸ | NPY4R | P50391 | 7/20 | 0.35 |
| ▸ | NPY1R | P25929 | 4/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | OTC | P00480 | 1/20 | 0.33 |
| ▸ | NPY2R | P49146 | 2/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL367998 | 1.00 | DDAH1 (0.43) | DDAH1MAPTCACNA1BAPBA1NPY4R | |
| Hydrochloric Acid SCHEMBL3432002 | 0.99 | DDAH1 (0.42) | DDAH1MAPTCACNA1BAPBA1NPY4R | |
| SCHEMBL26655366 | 0.88 | DDAH1 (0.45) | DDAH1MAPTCACNA1BAPBA1DPP7 | |
| SCHEMBL21327788 | 0.84 | DDAH1 (0.41) | DDAH1NPY4RNPY1RDPP7OTC | |
| SCHEMBL8414057 | 0.81 | NPY4R (0.38) | DDAH1NPY4RNPY1RDPP7OTC | |
| SCHEMBL11897923 | 0.81 | NPY4R (0.38) | DDAH1NPY4RNPY1RDPP7OTC | |
| SCHEMBL28985416 | 0.81 | DDAH1 (0.39) | DDAH1NPY4RNPY1RDPP7OTC | |
| SCHEMBL9237239 | 0.81 | NPY4R (0.39) | DDAH1NPY4RNPY1RDPP7OTC | |
| SCHEMBL28712062 | 0.81 | NPY4R (0.39) | DDAH1NPY4RNPY1RDPP7OTC | |
| SCHEMBL288133 | 0.81 | NPY4R (0.39) | DDAH1NPY4RNPY1RDPP7OTC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106414694-B | Enzyme treatment composition | 荷兰联合利华有限公司 | 2020-05-29 | — | — | CN | claimed |
| CN-106536700-B | Filth disposal composition | 荷兰联合利华有限公司 | 2019-03-26 | — | — | CN | claimed |
| EP-3158044-B1 | ENZYME TREATMENT COMPOSITION | UNILEVER PLC (GB) | 2018-06-06 | — | — | EP | claimed |
| EP-3182956-A1 | MOUTHWASH COMPOSITION COMPRISING A PEROXIDE SOURCE AND AN N-ACYL-L-ARGININE ALKYL ESTER SALT | Colgate-Palmolive Company (US) | 2017-06-28 | — | — | EP | claimed |
| EP-3158046-A1 | STAIN TREATMENT COMPOSITIONS | Unilever PLC (GB) | 2017-04-26 | — | — | EP | claimed |
| EP-3158044-A1 | ENZYME TREATMENT COMPOSITION | Unilever PLC (GB) | 2017-04-26 | — | — | EP | claimed |
| CN-106536700-A | Stain treatment compositions | 荷兰联合利华有限公司 | 2017-03-22 | — | — | CN | claimed |
| CN-106414694-A | Enzyme treatment composition | 荷兰联合利华有限公司 | 2017-02-15 | — | — | CN | claimed |
| WO-2016028265-A1 | MOUTHWASH COMPOSITION COMPRISING A PEROXIDE SOURCE AND AN N-ACYL-L-ARGININE ALKYL ESTER SALT | COLGATE-PALMOLIVE COMPANY (US) | 2016-02-25 | — | — | WO | claimed |
| WO-2015193205-A1 | STAIN TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2015-12-23 | — | — | WO | claimed |
| WO-2015193206-A1 | ENZYME TREATMENT COMPOSITION | UNILEVER PLC (GB) | 2015-12-23 | — | — | WO | claimed |
| US-20140179640-A1 | TOPICAL COMPOSITIONS FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS | EVOLOGIE LLC (US) | 2014-06-26 | — | — | US | claimed |
| WO-2012177433-A1 | TOPICAL COMPOSITIONS FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS | EVOLOGIE LLC (US) | 2012-12-27 | — | — | WO | claimed |
| CN-101262907-A | Oral compositions containing cationic active ingredients | COLGATE PALMOLIVE CO (US) | 2008-09-10 | — | — | CN | claimed |
| EP-1904185-A2 | ORAL COOMPOSITIONS HAVING CATIONIC ACTIVE INGREDIENTS | Colgate-Palmolive Company (US) | 2008-04-02 | — | — | EP | claimed |
| WO-2007011552-A2 | ORAL COOMPOSITIONS HAVING CATIONIC ACTIVE INGREDIENTS | COLGATE-PALMOLIVE COMPANY (US) | 2007-01-25 | — | — | WO | claimed |
| US-20070014740-A1 | Oral compositions having cationic active ingredients | COLGATE-PALMOLIVE COMPANY | 2007-01-18 | — | — | US | claimed |
| US-20240091112-A1 | Oral Compositions and Methods | COLGATE-PALMOLIVE COMPANY | 2024-03-21 | — | — | US | disclosed |
| WO-2004052405-A1 | ORAL FORMULATIONS FOR POORLY ABSORPTIVE HYDROPHILIC DRUGS | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2004-06-24 | — | — | WO | disclosed |
| US-5304470-A | Process for the enzymatic preparation of protected and unprotected di- and oligopeptides in aqueous solutions | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 1994-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070014740-A1 | Oral compositions having cationic active ingredients | EXOSC9, TAS2R7, TAS2R39 | DDAH1 2171/4885MAPT 2338/4885CACNA1B 2782/4885 |
| US-20140179640-A1 | TOPICAL COMPOSITIONS FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS | TYR, ALAD, ASS1 | DDAH1 2440/4885MAPT 2508/4885CACNA1B 4860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.